Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research

In the last decade, relevant advances have occurred in the treatment of hepatocellular carcinoma (HCC), with novel drugs entering the clinical practice, among which tyrosine kinase inhibitors (TKIs) such as lenvatinib, cabozantinib and regorafenib, and immune checkpoint inhibitors (ICPIs) either alo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornari, Francesca, Giovannini, Catia, Piscaglia, Fabio, Gramantieri, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744868/
https://www.ncbi.nlm.nih.gov/pubmed/36523954
http://dx.doi.org/10.2147/JHC.S347946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744868/
https://www.ncbi.nlm.nih.gov/pubmed/36523954
http://dx.doi.org/10.2147/JHC.S347946

Ejemplares similares